Literature DB >> 16643975

Cyclophilin A: an auxiliary but not necessary cofactor for TRIM5alpha restriction of HIV-1.

Matthew Stremlau1, Byeongwoon Song, Hassan Javanbakht, Michel Perron, Joseph Sodroski.   

Abstract

Cyclophilin A (Cyp A) binds the human immunodeficiency virus type 1 (HIV-1) capsid (CA) protein and contributes to the early events in virus replication in some cells. The retroviral restriction factor TRIM5alpha can inhibit the early, post-entry phase of infection by associating with the incoming viral capsid. Cyp A has been proposed to prevent restriction factor binding in human cells, thus enhancing HIV-1 infectivity, and to potentiate restriction of HIV-1 in monkey cells. Here we show that the positive effects of Cyp A-CA binding on HIV-1 infectivity do not depend on human TRIM5alpha. Disruption of Cyp A binding to CA partially relieved the block to HIV-1 infection imposed by several TRIM5alpha variants, but Cyp A-CA binding was not absolutely required for TRIM5alpha antiviral activity. Inhibition of Cyp A function by cyclosporine significantly decreased the efficiency of TRIM5alpha-mediated restriction only when the restricted virus capsid interacted with Cyp A.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16643975     DOI: 10.1016/j.virol.2006.03.015

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  50 in total

1.  Modulation of TRIM5alpha activity in human cells by alternatively spliced TRIM5 isoforms.

Authors:  Emilie Battivelli; Julie Migraine; Denise Lecossier; Saori Matsuoka; Danielle Perez-Bercoff; Sentob Saragosti; François Clavel; Allan J Hance
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  A new functional role of HIV-1 integrase during uncoating of the viral core.

Authors:  Marisa S Briones; Samson A Chow
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

Review 3.  Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection.

Authors:  Jeremy Luban
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

4.  The ability of multimerized cyclophilin A to restrict retrovirus infection.

Authors:  Hassan Javanbakht; Felipe Diaz-Griffero; Wen Yuan; Darwin F Yeung; Xing Li; Byeongwoon Song; Joseph Sodroski
Journal:  Virology       Date:  2007-06-15       Impact factor: 3.616

5.  Determinants of cyclophilin A-dependent TRIM5 alpha restriction against HIV-1.

Authors:  Tsai-Yu Lin; Michael Emerman
Journal:  Virology       Date:  2008-08-03       Impact factor: 3.616

Review 6.  Retroviral restriction and dependency factors in primates and carnivores.

Authors:  Hind J Fadel; Eric M Poeschla
Journal:  Vet Immunol Immunopathol       Date:  2011-06-12       Impact factor: 2.046

7.  Cyclophilin A-dependent restriction of human immunodeficiency virus type 1 capsid mutants for infection of nondividing cells.

Authors:  Mingli Qi; Ruifeng Yang; Christopher Aiken
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

8.  Porcine endogenous retroviruses PERV A and A/C recombinant are insensitive to a range of divergent mammalian TRIM5alpha proteins including human TRIM5alpha.

Authors:  Andrew Wood; Benjamin L J Webb; Birke Bartosch; Torsten Schaller; Yasuhiro Takeuchi; Greg J Towers
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

9.  Multiple sites in the N-terminal half of simian immunodeficiency virus capsid protein contribute to evasion from rhesus monkey TRIM5α-mediated restriction.

Authors:  Ken Kono; Haihan Song; Masaru Yokoyama; Hironori Sato; Tatsuo Shioda; Emi E Nakayama
Journal:  Retrovirology       Date:  2010-09-08       Impact factor: 4.602

Review 10.  Human immunodeficiency virus, restriction factors, and interferon.

Authors:  Stuart Neil; Paul Bieniasz
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.